ALDEYRA THERAPEUTICS INC shareholders Q3 2023

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AQR Capital Management 20,913$139,6990.00%
JPMORGAN CHASE & CO 31,927$213,2730.00%
CREDIT SUISSE AG/ 54,203$362,0750.00%
Parallax Volatility Advisers, L.P. 13,400$89,5120.00%
Nuveen Asset Management, LLC 185,976$1,242,3200.00%
UBS ASSET MANAGEMENT AMERICAS LLC 11,212$74,8960.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 51$3410.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 125,525$838,5070.00%
GOLDMAN SACHS GROUP INC 168,683$1,126,8030.00%
MORGAN STANLEY 249,115$1,664,0880.00%
COMERICA BANK 75$5010.00%
Invesco Ltd. 48,078$321,1610.00%
AMALGAMATED BANK 7,061$470.00%
WOLVERINE TRADING, LLC 20,266$135,3770.00%
RHUMBLINE ADVISERS 62,512$417,5700.00%
ALLIANCEBERNSTEIN L.P. 50,440$336,9390.00%
Allspring Global Investments Holdings, LLC 18,618$124,3680.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 12,270$81,9640.00%
UBS Group AG 74,595$498,2950.00%
RAYMOND JAMES & ASSOCIATES 51,051$341,0210.00%
External links

This page lists ALDEYRA THERAPEUTICS INC's shareholders in Q3 2023. To view ALDEYRA THERAPEUTICS INC's shareholder history, click here.